Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase NA 16Phase 1 10Phase 3 6Phase 1/2 4Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Genitourinary 4Thoracic 2Breast 2

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Lymphatic Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Capecitabine 17Paclitaxel 16Docetaxel 13Carboplatin 12Cyclophosphamide 11Gemcitabine 9Epirubicin 9Trastuzumab 8Letrozole 8Doxorubicin 7pertuzumab 5Cisplatin 5Vinorelbine 4130-nm albumin-bound paclitaxel 4exemestane 3Zoledronic Acid 3Tamoxifen 3Neoadjuvant Therapy 3Lapatinib 3Injections 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3pyrotinib 2palbociclib 2camrelizumab 2apatinib 2Thiotepa 2Taxes 2Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Radiosurgery × Breast × Clear all
NCT02364557 2026-05-19

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NRG Oncology

Phase 2/3 Completed
129 enrolled 23 charts
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT02759783 2019-08-21

CORE

Royal Marsden NHS Foundation Trust

Phase 2/3 Unknown
245 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡